Literature DB >> 20017195

Energy addiction and lymphocyte differentiation: a new role for the liver kinase B1 kinase.

Iannis Aifantis1, Catherine Sawai.   

Abstract

Lymphocyte development is a process in which proliferation is coupled to differentiation. In order to undergo efficient proliferation, lymphocytes must coordinate the entry into cell cycle with increased metabolism. The signaling pathways, like those downstream of antigen and cytokine receptors, and specific regulators that directly control cell metabolism are only beginning to be defined. A study in this issue of the European Journal of Immunology, demonstrates that the liver kinase B1 (LKB1) is a regulator of cellular metabolism. Deficiency in LKB1 results in a block in T-cell differentiation, increased apoptosis, as well as impaired survival of mature T cells. This study highlights the importance of LKB1 in T-cell development and function, but as discussed in this Commentary, a number of intriguing questions concerning the regulation and additional functions of LKB1 remain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20017195     DOI: 10.1002/eji.200940206

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

Review 1.  Metabolic remodeling in early development and cardiomyocyte maturation.

Authors:  Rebecca Ellen Kreipke; Yuliang Wang; Jason Wayne Miklas; Julie Mathieu; Hannele Ruohola-Baker
Journal:  Semin Cell Dev Biol       Date:  2016-02-18       Impact factor: 7.727

2.  The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.

Authors:  Piyawan Bunpo; Judy K Cundiff; Rachel B Reinert; Ronald C Wek; Carla J Aldrich; Tracy G Anthony
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

3.  LKB1 suppresses androgen synthesis in a mouse model of hyperandrogenism via IGF-1 signaling.

Authors:  Ying Xu; Yongxing Gao; Zufang Huang; Yan Zheng; Wenjuan Teng; Deyan Zheng; Xiaohua Zheng
Journal:  FEBS Open Bio       Date:  2019-09-12       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.